Annual CFO
$776.50 M
+$52.50 M+7.25%
31 December 2023
Summary:
West Pharmaceutical Services annual cash flow from operations is currently $776.50 million, with the most recent change of +$52.50 million (+7.25%) on 31 December 2023. During the last 3 years, it has risen by +$304.00 million (+64.34%). WST annual CFO is now at all-time high.WST Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$180.10 M
+$15.10 M+9.15%
30 September 2024
Summary:
West Pharmaceutical Services quarterly cash flow from operations is currently $180.10 million, with the most recent change of +$15.10 million (+9.15%) on 30 September 2024. Over the past year, it has dropped by -$50.00 million (-21.73%). WST quarterly CFO is now -24.68% below its all-time high of $239.10 million, reached on 31 December 2023.WST Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$702.40 M
-$50.00 M-6.65%
30 September 2024
Summary:
West Pharmaceutical Services TTM cash flow from operations is currently $702.40 million, with the most recent change of -$50.00 million (-6.65%) on 30 September 2024. Over the past year, it has dropped by -$65.80 million (-8.57%). WST TTM CFO is now -9.54% below its all-time high of $776.50 million, reached on 31 December 2023.WST TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WST Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.3% | -21.7% | -8.6% |
| 3 y3 years | +64.3% | -5.3% | +22.8% |
| 5 y5 years | +169.1% | +66.6% | +110.3% |
WST Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.3% | -24.7% | +52.4% | -9.5% | +22.8% |
| 5 y | 5 years | at high | +169.1% | -24.7% | +215.4% | -9.5% | +110.3% |
| alltime | all time | at high | +2183.8% | -24.7% | +2710.1% | -9.5% | +7067.4% |
West Pharmaceutical Services Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $180.10 M(+9.2%) | $702.40 M(-6.6%) |
| June 2024 | - | $165.00 M(+39.6%) | $752.40 M(-0.6%) |
| Mar 2024 | - | $118.20 M(-50.6%) | $756.60 M(-2.6%) |
| Dec 2023 | $776.50 M(+7.3%) | $239.10 M(+3.9%) | $776.50 M(+1.1%) |
| Sept 2023 | - | $230.10 M(+36.0%) | $768.20 M(+8.7%) |
| June 2023 | - | $169.20 M(+22.5%) | $707.00 M(-0.5%) |
| Mar 2023 | - | $138.10 M(-40.2%) | $710.90 M(-1.8%) |
| Dec 2022 | $724.00 M(+24.0%) | $230.80 M(+36.6%) | $724.00 M(+10.7%) |
| Sept 2022 | - | $168.90 M(-2.4%) | $654.00 M(-3.1%) |
| June 2022 | - | $173.10 M(+14.5%) | $675.20 M(+4.4%) |
| Mar 2022 | - | $151.20 M(-6.0%) | $646.50 M(+10.7%) |
| Dec 2021 | $584.00 M(+23.6%) | $160.80 M(-15.4%) | $584.00 M(+2.1%) |
| Sept 2021 | - | $190.10 M(+31.6%) | $571.90 M(+14.3%) |
| June 2021 | - | $144.40 M(+62.8%) | $500.40 M(-0.7%) |
| Mar 2021 | - | $88.70 M(-40.3%) | $504.10 M(+6.7%) |
| Dec 2020 | $472.50 M(+28.7%) | $148.70 M(+25.4%) | $472.50 M(+9.8%) |
| Sept 2020 | - | $118.60 M(-19.9%) | $430.20 M(+2.5%) |
| June 2020 | - | $148.10 M(+159.4%) | $419.70 M(+11.4%) |
| Mar 2020 | - | $57.10 M(-46.3%) | $376.70 M(+2.6%) |
| Dec 2019 | $367.20 M(+27.2%) | $106.40 M(-1.6%) | $367.20 M(+9.9%) |
| Sept 2019 | - | $108.10 M(+2.9%) | $334.00 M(+6.3%) |
| June 2019 | - | $105.10 M(+120.8%) | $314.30 M(+7.9%) |
| Mar 2019 | - | $47.60 M(-35.0%) | $291.20 M(+0.9%) |
| Dec 2018 | $288.60 M(+9.6%) | $73.20 M(-17.2%) | $288.60 M(-2.8%) |
| Sept 2018 | - | $88.40 M(+7.8%) | $296.90 M(+4.4%) |
| June 2018 | - | $82.00 M(+82.2%) | $284.30 M(-1.1%) |
| Mar 2018 | - | $45.00 M(-44.8%) | $287.60 M(+9.2%) |
| Dec 2017 | $263.30 M(+20.0%) | $81.50 M(+7.5%) | $263.30 M(+3.8%) |
| Sept 2017 | - | $75.80 M(-11.1%) | $253.60 M(+3.0%) |
| June 2017 | - | $85.30 M(+312.1%) | $246.20 M(+3.8%) |
| Mar 2017 | - | $20.70 M(-71.2%) | $237.10 M(+8.1%) |
| Dec 2016 | $219.40 M(+3.3%) | $71.80 M(+5.0%) | $219.40 M(+1.8%) |
| Sept 2016 | - | $68.40 M(-10.2%) | $215.60 M(-0.2%) |
| June 2016 | - | $76.20 M(+2440.0%) | $216.00 M(-0.6%) |
| Mar 2016 | - | $3.00 M(-95.6%) | $217.30 M(+2.3%) |
| Dec 2015 | $212.40 M(+16.1%) | $68.00 M(-1.2%) | $212.40 M(+11.6%) |
| Sept 2015 | - | $68.80 M(-11.2%) | $190.40 M(+2.6%) |
| June 2015 | - | $77.50 M(-4178.9%) | $185.50 M(+7.7%) |
| Mar 2015 | - | -$1.90 M(-104.1%) | $172.20 M(-5.9%) |
| Dec 2014 | $182.90 M(-17.1%) | $46.00 M(-28.0%) | $182.90 M(-11.1%) |
| Sept 2014 | - | $63.90 M(-0.5%) | $205.70 M(+5.4%) |
| June 2014 | - | $64.20 M(+629.5%) | $195.10 M(-7.3%) |
| Mar 2014 | - | $8.80 M(-87.2%) | $210.40 M(-4.6%) |
| Dec 2013 | $220.50 M(+17.7%) | $68.80 M(+29.1%) | $220.50 M(-0.5%) |
| Sept 2013 | - | $53.30 M(-33.0%) | $221.50 M(+0.8%) |
| June 2013 | - | $79.50 M(+320.6%) | $219.80 M(+14.2%) |
| Mar 2013 | - | $18.90 M(-72.9%) | $192.50 M(+2.7%) |
| Dec 2012 | $187.40 M(+43.4%) | $69.80 M(+35.3%) | $187.40 M(+17.6%) |
| Sept 2012 | - | $51.60 M(-1.1%) | $159.40 M(+8.1%) |
| June 2012 | - | $52.20 M(+278.3%) | $147.50 M(+9.3%) |
| Mar 2012 | - | $13.80 M(-67.0%) | $135.00 M(+3.3%) |
| Dec 2011 | $130.70 M(-5.5%) | $41.80 M(+5.3%) | $130.70 M(-4.0%) |
| Sept 2011 | - | $39.70 M(0.0%) | $136.10 M(-5.7%) |
| June 2011 | - | $39.70 M(+317.9%) | $144.40 M(+5.9%) |
| Mar 2011 | - | $9.50 M(-79.9%) | $136.30 M(-1.4%) |
| Dec 2010 | $138.30 M(+0.4%) | $47.20 M(-1.7%) | $138.30 M(-3.8%) |
| Sept 2010 | - | $48.00 M(+51.9%) | $143.70 M(+6.7%) |
| June 2010 | - | $31.60 M(+174.8%) | $134.70 M(-11.7%) |
| Mar 2010 | - | $11.50 M(-78.1%) | $152.50 M(+10.7%) |
| Dec 2009 | $137.70 M(+2.0%) | $52.60 M(+34.9%) | $137.70 M(+6.7%) |
| Sept 2009 | - | $39.00 M(-21.1%) | $129.10 M(-2.3%) |
| June 2009 | - | $49.40 M(-1597.0%) | $132.20 M(-4.6%) |
| Mar 2009 | - | -$3.30 M(-107.5%) | $138.60 M(+2.7%) |
| Dec 2008 | $135.00 M(+4.5%) | $44.00 M(+4.5%) | $135.00 M(-10.2%) |
| Sept 2008 | - | $42.10 M(-24.6%) | $150.30 M(+13.5%) |
| June 2008 | - | $55.80 M(-908.7%) | $132.40 M(+11.3%) |
| Mar 2008 | - | -$6.90 M(-111.6%) | $119.00 M(-7.9%) |
| Dec 2007 | $129.20 M | $59.30 M(+145.0%) | $129.20 M(+10.1%) |
| Sept 2007 | - | $24.20 M(-42.9%) | $117.40 M(-9.3%) |
| June 2007 | - | $42.40 M(+1184.8%) | $129.50 M(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $3.30 M(-93.1%) | $144.10 M(+0.2%) |
| Dec 2006 | $143.80 M(+80.2%) | $47.50 M(+30.9%) | $143.80 M(+25.7%) |
| Sept 2006 | - | $36.30 M(-36.3%) | $114.40 M(+1.3%) |
| June 2006 | - | $57.00 M(+1800.0%) | $112.90 M(+35.0%) |
| Mar 2006 | - | $3.00 M(-83.4%) | $83.60 M(+4.8%) |
| Dec 2005 | $79.80 M(+15.5%) | $18.10 M(-48.0%) | $79.80 M(-7.3%) |
| Sept 2005 | - | $34.80 M(+25.6%) | $86.10 M(+24.2%) |
| June 2005 | - | $27.70 M(-3562.5%) | $69.30 M(+18.7%) |
| Mar 2005 | - | -$800.00 K(-103.3%) | $58.40 M(-15.5%) |
| Dec 2004 | $69.10 M(+0.4%) | $24.40 M(+35.6%) | $69.10 M(+9.3%) |
| Sept 2004 | - | $18.00 M(+7.1%) | $63.20 M(-9.5%) |
| June 2004 | - | $16.80 M(+69.7%) | $69.80 M(+8.0%) |
| Mar 2004 | - | $9.90 M(-46.5%) | $64.60 M(-6.1%) |
| Dec 2003 | $68.80 M(+31.8%) | $18.50 M(-24.8%) | $68.80 M(+20.5%) |
| Sept 2003 | - | $24.60 M(+112.1%) | $57.10 M(0.0%) |
| June 2003 | - | $11.60 M(-17.7%) | $57.10 M(-3.7%) |
| Mar 2003 | - | $14.10 M(+107.4%) | $59.30 M(+13.6%) |
| Dec 2002 | $52.20 M(+37.0%) | $6.80 M(-72.4%) | $52.20 M(-16.9%) |
| Sept 2002 | - | $24.60 M(+78.3%) | $62.80 M(+44.0%) |
| June 2002 | - | $13.80 M(+97.1%) | $43.60 M(-4.0%) |
| Mar 2002 | - | $7.00 M(-59.8%) | $45.40 M(+19.2%) |
| Dec 2001 | $38.10 M(-2.3%) | $17.40 M(+222.2%) | $38.10 M(+61.4%) |
| Sept 2001 | - | $5.40 M(-65.4%) | $23.60 M(-21.9%) |
| June 2001 | - | $15.60 M(-5300.0%) | $30.20 M(+7.1%) |
| Mar 2001 | - | -$300.00 K(-110.3%) | $28.20 M(-27.7%) |
| Dec 2000 | $39.00 M(-43.8%) | $2.90 M(-75.8%) | $39.00 M(-37.6%) |
| Sept 2000 | - | $12.00 M(-11.8%) | $62.50 M(-1.1%) |
| June 2000 | - | $13.60 M(+29.5%) | $63.20 M(-5.0%) |
| Mar 2000 | - | $10.50 M(-60.2%) | $66.50 M(-4.2%) |
| Dec 1999 | $69.40 M(-2.3%) | $26.40 M(+107.9%) | $69.40 M(-2.5%) |
| Sept 1999 | - | $12.70 M(-24.9%) | $71.20 M(-16.2%) |
| June 1999 | - | $16.90 M(+26.1%) | $85.00 M(+11.8%) |
| Mar 1999 | - | $13.40 M(-52.5%) | $76.00 M(+7.0%) |
| Dec 1998 | $71.00 M(+4.9%) | $28.20 M(+6.4%) | $71.00 M(+31.7%) |
| Sept 1998 | - | $26.50 M(+235.4%) | $53.90 M(+9.8%) |
| June 1998 | - | $7.90 M(-6.0%) | $49.10 M(-24.6%) |
| Mar 1998 | - | $8.40 M(-24.3%) | $65.10 M(-3.8%) |
| Dec 1997 | $67.70 M(+6.8%) | $11.10 M(-48.8%) | $67.70 M(-7.6%) |
| Sept 1997 | - | $21.70 M(-9.2%) | $73.30 M(-3.2%) |
| June 1997 | - | $23.90 M(+117.3%) | $75.70 M(+19.4%) |
| Mar 1997 | - | $11.00 M(-34.1%) | $63.40 M(0.0%) |
| Dec 1996 | $63.40 M(+37.5%) | $16.70 M(-30.7%) | $63.40 M(+6.0%) |
| Sept 1996 | - | $24.10 M(+107.8%) | $59.80 M(+13.0%) |
| June 1996 | - | $11.60 M(+5.5%) | $52.90 M(+5.6%) |
| Mar 1996 | - | $11.00 M(-16.0%) | $50.10 M(+8.7%) |
| Dec 1995 | $46.10 M(-7.4%) | $13.10 M(-23.8%) | $46.10 M(-8.0%) |
| Sept 1995 | - | $17.20 M(+95.5%) | $50.10 M(+3.5%) |
| June 1995 | - | $8.80 M(+25.7%) | $48.40 M(-2.8%) |
| Mar 1995 | - | $7.00 M(-59.1%) | $49.80 M(0.0%) |
| Dec 1994 | $49.80 M(+29.4%) | $17.10 M(+10.3%) | $49.80 M(+1.6%) |
| Sept 1994 | - | $15.50 M(+52.0%) | $49.00 M(+20.7%) |
| June 1994 | - | $10.20 M(+45.7%) | $40.60 M(-4.9%) |
| Mar 1994 | - | $7.00 M(-57.1%) | $42.70 M(+10.9%) |
| Dec 1993 | $38.50 M(+13.2%) | $16.30 M(+129.6%) | $38.50 M(+11.9%) |
| Sept 1993 | - | $7.10 M(-42.3%) | $34.40 M(-12.5%) |
| June 1993 | - | $12.30 M(+339.3%) | $39.30 M(-1.5%) |
| Mar 1993 | - | $2.80 M(-77.0%) | $39.90 M(+17.4%) |
| Dec 1992 | $34.00 M(-23.4%) | $12.20 M(+1.7%) | $34.00 M(-6.1%) |
| Sept 1992 | - | $12.00 M(-7.0%) | $36.20 M(-2.7%) |
| June 1992 | - | $12.90 M(-516.1%) | $37.20 M(+6.3%) |
| Mar 1992 | - | -$3.10 M(-121.5%) | $35.00 M(-21.2%) |
| Dec 1991 | $44.40 M(+23.3%) | $14.40 M(+10.8%) | $44.40 M(+17.5%) |
| Sept 1991 | - | $13.00 M(+21.5%) | $37.80 M(+6.8%) |
| June 1991 | - | $10.70 M(+69.8%) | $35.40 M(+8.9%) |
| Mar 1991 | - | $6.30 M(-19.2%) | $32.50 M(-9.7%) |
| Dec 1990 | $36.00 M(-16.1%) | $7.80 M(-26.4%) | $36.00 M(+27.7%) |
| Sept 1990 | - | $10.60 M(+35.9%) | $28.20 M(+60.2%) |
| June 1990 | - | $7.80 M(-20.4%) | $17.60 M(+79.6%) |
| Mar 1990 | - | $9.80 M | $9.80 M |
| Dec 1989 | $42.90 M | - | - |
FAQ
- What is West Pharmaceutical Services annual cash flow from operations?
- What is the all time high annual CFO for West Pharmaceutical Services?
- What is West Pharmaceutical Services annual CFO year-on-year change?
- What is West Pharmaceutical Services quarterly cash flow from operations?
- What is the all time high quarterly CFO for West Pharmaceutical Services?
- What is West Pharmaceutical Services quarterly CFO year-on-year change?
- What is West Pharmaceutical Services TTM cash flow from operations?
- What is the all time high TTM CFO for West Pharmaceutical Services?
- What is West Pharmaceutical Services TTM CFO year-on-year change?
What is West Pharmaceutical Services annual cash flow from operations?
The current annual CFO of WST is $776.50 M
What is the all time high annual CFO for West Pharmaceutical Services?
West Pharmaceutical Services all-time high annual cash flow from operations is $776.50 M
What is West Pharmaceutical Services annual CFO year-on-year change?
Over the past year, WST annual cash flow from operations has changed by +$52.50 M (+7.25%)
What is West Pharmaceutical Services quarterly cash flow from operations?
The current quarterly CFO of WST is $180.10 M
What is the all time high quarterly CFO for West Pharmaceutical Services?
West Pharmaceutical Services all-time high quarterly cash flow from operations is $239.10 M
What is West Pharmaceutical Services quarterly CFO year-on-year change?
Over the past year, WST quarterly cash flow from operations has changed by -$50.00 M (-21.73%)
What is West Pharmaceutical Services TTM cash flow from operations?
The current TTM CFO of WST is $702.40 M
What is the all time high TTM CFO for West Pharmaceutical Services?
West Pharmaceutical Services all-time high TTM cash flow from operations is $776.50 M
What is West Pharmaceutical Services TTM CFO year-on-year change?
Over the past year, WST TTM cash flow from operations has changed by -$65.80 M (-8.57%)